CIK 0001368514
- Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562590442
- Phone
- +1 201-478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award President and CEO acquired 100,000 shares (grant or award)
- 4 Grant or award EVP, CFO acquired 40,000 shares (grant or award)
- 4 Grant or award EVP, CSO and CMO acquired 40,000 shares (grant or award)
- 4 Open-market buy Director bought 20,000 shares at $3.50 ($70,000)
- 4 Open-market buy CSO and CMO bought 4,285 shares at $3.50 ($14,998)
- 4 Open-market buy Director bought 45,714 shares at $3.50 ($159,999)
- 4 Open-market buy EVP, CFO bought 7,142 shares at $3.50 ($24,997)
- 4 Open-market buy President and CEO bought 85,714 shares at $3.50 ($299,999)
- 4 Open-market buy 10% owner bought 4,563,700 shares at $3.50 ($15,972,950)
- 4 Open-market sale 10% owner sold 5,813,954 shares at $3.75 ($21,802,328)
- 4 Open-market buy 10% owner bought 4,000,000 shares at $4.00 ($16,000,000)
- 4 Open-market buy Director bought 12,000 shares at $4.00 ($48,000)
- 4 Open-market buy Director bought 25,000 shares at $4.00 ($100,000)
- 4 Open-market buy EVP, CSO and CMO bought 4,500 shares at $4.00 ($18,000)
- 4 Open-market buy EVP, CFO bought 5,000 shares at $4.00 ($20,000)
Page 10 of 19 · 364 filings